The use of and adherence to CTCAE v3.0 in cancer clinical trial publications

BACKGROUND: The Common Terminology Criteria for Adverse Events, Version 3.0 (CTCAE v3.0) was released in 2003, and has been widely used as the predominant set of toxicity criteria for cancer clinical trials and scientific meetings. However, the degree to which the elements of CTCAE v3.0 are followed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sheng, Chen, Qiang, Wang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323176/
https://www.ncbi.nlm.nih.gov/pubmed/27564109
http://dx.doi.org/10.18632/oncotarget.11576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323176/
https://www.ncbi.nlm.nih.gov/pubmed/27564109
http://dx.doi.org/10.18632/oncotarget.11576

Ejemplares similares